OPT
Click for more information
1.47% 34.5¢ opthea limited

Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024, page-37

  1. PigRace
    102 Posts.
    lightbulb Created with Sketch. 86
    clock Created with Sketch.
    11/05/24
    22:06
    Post #: 73781218
    CATT of course tested ranibizumab (Lucentis) as the control against bevacizumab (Avastin) and not aflibercept (Eylea) against bevacizumab (Lucentis).

    Apologies. I was too late to edit my above post.
    OPT Price at posting: 68.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
NEWS The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
34.5¢ 		Change
0.005(1.47%) 		Mkt cap ! $376.5M
Open High Low Value Volume
34.0¢ 35.0¢ 33.5¢ $986.8K 2.875M

Buyers (Bids)

No. Vol. Price($)
2 55705 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 29727 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.